Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer
NCT00003395
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG:
arsenic trioxide
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]